These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience. Öngören Ş; Eşkazan AE; Berk S; Elverdi T; Salihoğlu A; Ar MC; Başlar Z; Aydın Y; Tüzüner N; Soysal T Turk J Haematol; 2017 Dec; 34(4):291-299. PubMed ID: 29199176 [TBL] [Abstract][Full Text] [Related]
27. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Babuŝíková O; Tomová A; Kusenda J; Gyárfás J Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978 [TBL] [Abstract][Full Text] [Related]
28. The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia. Piro LD; Ellison DJ; Saven A Leuk Lymphoma; 1994; 14 Suppl 1():121-5. PubMed ID: 7820043 [TBL] [Abstract][Full Text] [Related]
29. The optimal management of hairy cell leukaemia. Gollard R; Lee TC; Piro LD; Saven A Drugs; 1995 Jun; 49(6):921-31. PubMed ID: 7543840 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic advances in the treatment of hairy cell leukemia. Andrey J; Saven A Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103 [No Abstract] [Full Text] [Related]
31. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences). Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236 [TBL] [Abstract][Full Text] [Related]
33. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262 [TBL] [Abstract][Full Text] [Related]
34. Hairy cell leukemia: an elusive but treatable disease. Wanko SO; de Castro C Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237 [TBL] [Abstract][Full Text] [Related]
35. Second malignancies in patients with hairy cell leukemia in british columbia: a 20-year experience. Au WY; Klasa RJ; Gallagher R; Le N; Gascoyne RD; Connors JM Blood; 1998 Aug; 92(4):1160-4. PubMed ID: 9694703 [TBL] [Abstract][Full Text] [Related]
36. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Cheson BD; Vena DA; Barrett J; Freidlin B J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309 [TBL] [Abstract][Full Text] [Related]